Fab Biopharma

Fab Biopharma is pioneering drug discovery to improve women’s health. Autoimmune diseases such as Sjögren’s disease, lupus and osteoarthritis are more prevalent in women, but these diseases lack comprehensive treatment options. Our mission is to change that by creating safe and effective autoimmune biologics that work for women. Built by industry veterans with specialized expertise in IP, drug development, and clinical development, Fab Biopharma is developing a novel class of bispecific soluble receptors to target T and B cell activating cytokines and ligands. We understand that differences in female biology impact drug development, so we’re undertaking to innovate in drug science through R&D that takes a female-centered perspective.